In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting.
Name: Board of Scientific Counselors, National Center for Infectious Diseases (NCID).
Time and Date: 8:30 a.m.-3:30 p.m., December 6, 2001.
Place: CDC, Auditorium B, Building 1, Clifton Road, Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The Board of Scientific Counselors, NCID, provides advice and guidance to the Director, CDC, and Director, NCID, in the following areas: program goals and objectives; strategies; program organization and resources for infectious disease prevention and control; and program priorities.
Matters to be Discussed: Agenda items will include:
1. Opening Session: NCID Update
a. Institute of Medicine
b. Global Strategy
2. Program Update:
a. West Nile
e. Creutzfeldt-Jakob Disease
3. Bioterrorism Updates and Discussion
a. Organizational Approach/Structure
b. Anthrax Investigations
c. Smallpox Activities
d. Other issues, e.g., antimicrobial resistance/widespread use of antibiotics
4. Board meets with Director, CDC
5. Discussions and Recommendations Other agenda items include announcements/introductions; follow-up on actions recommended by the Board May 2001; consideration of future directions, goals, and recommendations.
Agenda items are subject to change as priorities dictate.
An unavoidable administrative delay prevented meeting the 15-day publication requirement. Start Printed Page 59023
Written comments are welcome and should be received by the contact person listed below prior to the opening of the meeting.
Contact Person For More Information: Diane S. Holley, Office of the Director, NCID, CDC, Mailstop C-19, 1600 Clifton Road, NE, Atlanta, Georgia 30333, email email@example.com; telephone 404/639-0078.
The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: November 15, 2001.
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 01-29338 Filed 11-23-01; 8:45 am]
BILLING CODE 4163-18-P